Trial intelligence / Profile preview

Celecoxib for Transitional Pain After Outpatient Surgery

NCT00664690Phase 4Withdrawn

Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative pain comparing Celebrex with Placebo (2 arms). Primary endpoint: Visual Analogue Score for Pain. Status: withdrawn.

02

Drugs

celecoxib
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00664690.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00664690.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call